Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background/aim: The perioperative period may influence immune function in cancer patients, with anesthetic agents potentially contributing to immunosuppression. This study evaluated the differential impact of fentanyl and remifentanil on immune cell populations in breast cancer (BCa) patients undergoing surgery.
Patients And Methods: Thirty patients with histologically confirmed BCa who were treated with modified radical mastectomy or breast-conserving surgery followed by radiotherapy were included in the study. Anesthesia was administered using either fentanyl (n=12) or remifentanil (n=18). White blood cell (WBC) and lymphocyte (LC) counts were recorded before and 24 h after surgery. Peripheral blood mononuclear cells were analyzed for T-cell subpopulations using flow cytometry.
Results: WBC counts increased from a median of 7,025/μl before to 10,065/μl after surgery (<0.0001), whilst LC counts were reduced from a median value of 1,785 to 1,090 (=0.0002). The median duration of anesthesia was 212 min. Patients who received remifentanil for a shorter anesthesia period (<212 min) experienced a marginal non-significant degree of leukocytosis (=0.07), while no lymphopenia was evident (=0.38). In contrast, longer remifentanil exposure significantly induced significant leukocytosis (=0.01) and lymphopenia (=0.009), similar to fentanyl. There were no significant differences between fentanyl and remifentanil in their effects on CD4+, CD8+, or CD4+/CD25+/FOXP3+ T-cell populations. Notably, the percentage of CD4+ T-cells was positively correlated with the duration of anesthesia (=0.002, r=0.53).
Conclusion: Optimizing analgesic selection and anesthesia duration may play a crucial role in minimizing immunosuppressive perioperative stress in patients undergoing BCa surgery. Remifentanil combined with shorter anesthesia exposure appears to mitigate immune suppression, suggesting a potential strategy to preserve immune competence during oncologic surgery.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21873/anticanres.17736 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Few reports exist in dentistry about the use of general anesthesia in children after liver transplant. In this paper, we report our experience utilizing general anesthesia for oral surgery in a 9-year-old girl who had undergone living donor liver transplantation. She was diagnosed with hepatoblastoma at 4 months of age and underwent a living donor liver transplant at 7 months of age.
View Article and Find Full Text PDFExpanding Fentanyl Analog Testing to Include Brain Specimens: Method Validation and Homogenate Stability Assessment.
J Anal Toxicol
September 2025
Harris County Institute of Forensic Sciences, 1861 Old Spanish Trail, Houston, TX, 77954, United States of America.
XXXXX recently added brain to its fentanyl analog testing method for 14 analogs (fluoroisobutyryl fentanyl, acetyl fentanyl, acryl fentanyl, alfentanil, butyryl fentanyl, carfentanil, fentanyl, para-fluorofentanyl, furanyl fentanyl, methoxyacetyl fentanyl, norcarfentanil, norfentanyl, sufentanil, and valeryl fentanyl) and 3 U-series drugs (U-47700, U-48800, and U-49900). Brain is a protected and isolated organ with lower metabolic activity than other tissues, which can assist in interpreting results and preserving parent drug. Limited publications testing brain samples for fentanyl and fentanyl analogs exist and none describe homogenate stability for these analytes.
View Article and Find Full Text PDFDoes the addition of fentanyl premedication impact brown fat uptake in children undergoing a warming protocol for FDG PET?
Pediatr Radiol
September 2025
University of Cincinnati, Cincinnati, United States.
Background: Fentanyl is used in some pediatric practices with a goal of suppressing 18F-fluorodeoxyglucose (18F-FDG) uptake in brown fat.
Objective: The purpose of this study was to examine the frequency, intensity, and distribution of brown fat uptake in warmed children undergoing 18F-FDG PET/CT with and without premedication with fentanyl. MATERIALS AND METHODS: This retrospective study included children (< 18 years old) who underwent 18F-FDG-PET from 2014 to 2024 at a center that routinely warms patients and uses intravenous fentanyl for brown fat suppression for most patients.
Neuraxial anesthesia and pain management for cesarean delivery.
Am J Obstet Gynecol
July 2025
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Palo Alto, CA.
Optimal neuraxial anesthesia for cesarean delivery requires a thorough understanding of patient, obstetrical, surgical, and anesthesia-related factors which can impact pain during and after cesarean delivery. While not all cesarean deliveries are the same from an obstetrical standpoint, not all anesthetics provide the same degree of anesthetic blockade and postcesarean analgesia; therefore, context is crucial to provide patients with a safe and pain-free experience. Communication between obstetrical and anesthesia teams is key to ensure that the anesthetic approach is tailored to the clinical scenario, particularly if emergency cesarean delivery is needed, and follows best practices for cesarean delivery anesthesia.
View Article and Find Full Text PDFConcordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Opioid Use Disorder: Concordance entre le dépistage de drogues dans l'urine et l'usage autodéclaré dans le contexte d'un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l'usage d'opioïdes vendus sur ordonnance.
Can J Psychiatry
August 2025
Department of Psychiatry and Addictology, Université de Montréal, Montréal, Canada.
Objective: In this study, we evaluated the concordance between urine drug screening (UDS) and self-reported use in a pragmatic randomized clinical trial.
Methods: Our data was drawn from OPTIMA, a 24-week pragmatic multicentric open-label randomized-controlled trial comparing flexible take-home dosing of buprenorphine/naloxone to the methadone standard model of care for treating prescription-type opioid use disorder. A total of 272 participants were randomized (1:1 ratio) to methadone or buprenorphine/naloxone.